GB1330805A - Immunization methods against toxic effects of bacterial infection - Google Patents
Immunization methods against toxic effects of bacterial infectionInfo
- Publication number
- GB1330805A GB1330805A GB1859972A GB1330805DA GB1330805A GB 1330805 A GB1330805 A GB 1330805A GB 1859972 A GB1859972 A GB 1859972A GB 1330805D A GB1330805D A GB 1330805DA GB 1330805 A GB1330805 A GB 1330805A
- Authority
- GB
- United Kingdom
- Prior art keywords
- elastase
- bacterial
- toxic effects
- bacterial infection
- immunization methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 231100000331 toxic Toxicity 0.000 title abstract 2
- 230000002588 toxic effect Effects 0.000 title abstract 2
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 238000007911 parenteral administration Methods 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 102000016387 Pancreatic elastase Human genes 0.000 abstract 1
- 108010067372 Pancreatic elastase Proteins 0.000 abstract 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6448—Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1330805 Treatment of bacterial-elastase infection RESEARCH CORP 21 April 1972 18599/72 Heading A5B The toxic effects of infection of a non-human animal by elastase-elaborating bacteria are minimized by parenteral administration of purified bacterial-elastase or immune serum containing antibodies against bacterial-elastase. The bacterial-elastase may be derived from Pseudomonas aeruginosa. The immune serum may be prepared by parenteral administration of bacterial elastase to another animal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1859972 | 1972-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1330805A true GB1330805A (en) | 1973-09-19 |
Family
ID=10115223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1859972A Expired GB1330805A (en) | 1972-04-21 | 1972-04-21 | Immunization methods against toxic effects of bacterial infection |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1330805A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2575068A1 (en) * | 1984-12-24 | 1986-06-27 | Commw Scient Ind Res Org | VACCINE FOR PROPHYLAXIS AND FORK TREATMENT, INCLUDING BACTEROID NODOSUS PROTEASE AS ACTIVE SUBSTANCE |
WO2003063895A1 (en) * | 2002-01-31 | 2003-08-07 | New York University | Treatment of bacterial infection with elastase |
-
1972
- 1972-04-21 GB GB1859972A patent/GB1330805A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2575068A1 (en) * | 1984-12-24 | 1986-06-27 | Commw Scient Ind Res Org | VACCINE FOR PROPHYLAXIS AND FORK TREATMENT, INCLUDING BACTEROID NODOSUS PROTEASE AS ACTIVE SUBSTANCE |
WO2003063895A1 (en) * | 2002-01-31 | 2003-08-07 | New York University | Treatment of bacterial infection with elastase |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE7761T1 (en) | VACCINE AND PRODUCTION PROCESS. | |
GB1499035A (en) | Antistaphylococcus human immune globulin and method of preparing same | |
EP0041897A3 (en) | Polysaccharide antigen from streptococcus and vaccine containing the same | |
BE746522A (en) | LAUNCHING PROCESS FOR THE PRODUCTION OF ETOFFES PRACTICALLY FREE OF BACTERIA AND BACTERIAL SPORES | |
AU548623B2 (en) | Production of antibodies | |
IT8023226A0 (en) | SYSTEM FOR THE INFUSION OF MEDICINES, MAGNETICALLY CONTROLLED. | |
BE759063A (en) | TRANSFORMATION OF ALDOSES INTO CETOSES BY FERMENTATION. | |
GB1330805A (en) | Immunization methods against toxic effects of bacterial infection | |
AU2456888A (en) | Monoclonal antibodies specific for HIV and hybridomas for their production | |
GB1188519A (en) | Method for the Purification of Lipopolysaccharides | |
CA980948A (en) | Copolymeres reticules d'acrylonitrile et de monomeres azotes | |
FR2180594A1 (en) | Reducing elastase - elaborating bacterial infection - using bacterial elastase as antigen | |
EP0327648A4 (en) | Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient. | |
IE32044L (en) | Tetanus vaccine | |
FR2453176A1 (en) | PROCESS FOR THE PREPARATION OF CEPHALOSPORINS SUBSTITUTED BY A CARBAMOYLOXYMETHYL GROUP IN POSITION 3 | |
GB1338459A (en) | Flavanone derivatives and process for inhibiting growth of microorganisms using such compounds | |
BE752918A (en) | ENZYMES OBTAINED BY CULTIVATION OF A CEPHALOSPORIUM SPECIES, AND METHODS FOR THEIR PREPARATION, ISOLATION AND PURIFICATION | |
CA972682A (en) | Immunization methods against toxic effects of bacterial infection | |
FR2499855B1 (en) | NOVEL CARCINOSTATIC AND IMMUNO-STIMULATING SUBSTANCES, PROCESS FOR PREPARING SAME FROM FUSOBACTERIUM BACTERIA, AND CARCINOSTATIC AGENT CONTAINING SUCH SUBSTANCES | |
CH449045A (en) | Process for the preparation of amino acids or their esters, the amino or imino group of which is protected by the t-amyloxycarbonyl group | |
AU3649071A (en) | The preparation of 3'-deoxykanamycin active against resistant bacteria | |
GB1254948A (en) | Antivirial substance | |
OA04275A (en) | New antibiotic, its preparation by culturing a streptomyces and compositions containing it. | |
CA962380A (en) | Procede et dispositif d'asservissement en position des faisceaux d'ions dans les spectometres de masse | |
GB1371693A (en) | 4,6-dihydro-1,3-dimethyl-4-ethyl-8-phenylpyrazolo-4,3-e-1,4- diazepin-5-1h-one and compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |